Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	48.91	38.75	96.34	24.49	42.75
Short-Term Investments	-	-	-	54.59	46.22
Cash & Short-Term Investments	48.91	38.75	96.34	79.08	88.97
Cash Growth	26.20%	-59.77%	21.83%	-11.12%	-43.39%
Other Receivables	2.6	-	-	-	-
Receivables	2.6	-	-	-	-
Prepaid Expenses	0.35	3.18	3.88	3.32	2.53
Restricted Cash	-	-	-	0.22	-
Other Current Assets	0.25	2.28	1.97	1	0.4
Total Current Assets	52.11	44.21	102.18	83.61	91.9
Property, Plant & Equipment	0.67	0.93	1.18	1.4	1.48
Long-Term Investments	-	-	-	-	32.46
Other Long-Term Assets	0.24	0.07	0.58	0.64	0.65
Total Assets	53.02	45.21	103.95	85.65	126.49
Accounts Payable	0.94	1.3	3.33	1.43	2.82
Accrued Expenses	8.83	12.05	14.35	9.26	5.69
Current Portion of Long-Term Debt	-	1.62	1.62	1.62	-
Current Portion of Leases	0.32	0.28	0.25	0.14	0.36
Current Unearned Revenue	-	-	4.91	-	-
Total Current Liabilities	10.09	15.25	24.47	12.45	8.87
Long-Term Debt	-	0.12	1.72	3.29	4.88
Long-Term Leases	0.42	0.74	1.02	1.26	1.29
Other Long-Term Liabilities	-	0.28	0.24	0.16	0.07
Total Liabilities	10.51	16.39	27.44	17.16	15.12
Common Stock	-	-	0	0	0
Additional Paid-In Capital	331.75	279.09	273.74	218.35	214.69
Retained Earnings	-289.23	-250.27	-197.23	-149.31	-103.13
Comprehensive Income & Other	-	-	-	-0.56	-0.18
Total Common Equity	42.52	28.82	76.51	68.49	111.37
Shareholders' Equity	42.52	28.82	76.51	68.49	111.37
Total Liabilities & Equity	53.02	45.21	103.95	85.65	126.49
Total Debt	0.74	2.77	4.61	6.32	6.53
Net Cash (Debt)	48.17	35.99	91.73	72.76	82.44
Net Cash Growth	33.85%	-60.77%	26.07%	-11.74%	-45.32%
Net Cash Per Share	62.84	65.42	178.65	231.95	264.66
Filing Date Shares Outstanding	1.37	0.56	0.55	0.53	0.31
Total Common Shares Outstanding	1.37	0.56	0.55	0.31	0.31
Working Capital	42.03	28.96	77.72	71.16	83.02
Book Value Per Share	30.99	51.18	139.85	217.64	355.56
Tangible Book Value	42.52	28.82	76.51	68.49	111.37
Tangible Book Value Per Share	30.99	51.18	139.85	217.64	355.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.